Smoking cessation and cardiovascular disease risk factors: Results from the Third National Health and Nutrition Examination Survey

被引:165
作者
Bakhru, A [1 ]
Erlinger, TP
机构
[1] Univ Rochester, Med Ctr, Sch Med, Rochester, NY 14642 USA
[2] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA
[3] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[4] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[5] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA
关键词
D O I
10.1371/journal.pmed.0020160
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Cigarette smoking is a major risk factor for the development and progression of cardiovascular disease. While smoking is associated with increased levels of inflammatory markers and accelerated atherosclerosis, few studies have examined the impact of smoking cessation on levels of inflammatory markers. The degree and rate at which inflammation subsides after smoking cessation are uncertain. It also remains unclear as to whether traditional risk factors can adequately explain the observed decline in cardiovascular risk following smoking cessation. Methods and Findings Using data from 15,489 individuals who participated in the Third National Health and Nutrition Examination Survey (NHANES III), we analyzed the association between smoking and smoking cessation on levels of inflammatory markers and traditional cardiovascular risk factors. In particular, we examined changes in C-reactive protein, white blood cell count, albumin, and fibrinogen. Inflammatory markers demonstrated a dose-dependent and temporal relationship to smoking and smoking cessation. Both inflammatory and traditional risk factors improved with decreased intensity of smoking. With increased time since smoking cessation, inflammatory markers resolved more slowly than traditional cardiovascular risk factors. Conclusion Inflammatory markers may be more accurate indicators of atherosclerotic disease. Inflammatory markers returned to baseline levels 5 y after smoking cessation, consistent with the time frame associated with cardiovascular risk reduction observed in both the MONICA and Northwick Park Heart studies. Our results suggest that the inflammatory component of cardiovascular disease resulting from smoking is reversible with reduced tobacco exposure and smoking cessation.
引用
收藏
页码:528 / 536
页数:9
相关论文
共 61 条
  • [11] Complement activation in heart diseases: Role of oxidants
    Chakraborti, T
    Mandal, A
    Mandal, M
    Das, S
    Chakraborti, S
    [J]. CELLULAR SIGNALLING, 2000, 12 (9-10) : 607 - 617
  • [12] COOK DG, 1986, LANCET, V2, P1376
  • [13] Risk factors for coronary heart disease and acute-phase proteins - A population-based study
    Danesh, J
    Muir, J
    Wong, YK
    Ward, M
    Gallimore, JR
    Pepys, MB
    [J]. EUROPEAN HEART JOURNAL, 1999, 20 (13) : 954 - 959
  • [14] Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
    Danesh, J
    Whincup, P
    Walker, M
    Lennon, L
    Thomson, A
    Appleby, P
    Gallimore, JR
    Pepys, MB
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7255): : 199 - 204
  • [15] Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies
    Danesh, J
    Collins, R
    Appleby, P
    Peto, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18): : 1477 - 1482
  • [16] Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers
    deMaat, MPM
    Pietersma, A
    Kofflard, M
    Sluiter, W
    Kluft, C
    [J]. ATHEROSCLEROSIS, 1996, 121 (02) : 185 - 191
  • [17] HOW SOON AFTER QUITTING SMOKING DOES RISK OF HEART-ATTACK DECLINE
    DOBSON, AJ
    ALEXANDER, HM
    HELLER, RF
    LLOYD, DM
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1991, 44 (11) : 1247 - 1253
  • [18] Eliasson B, 2001, Nicotine Tob Res, V3, P249, DOI 10.1080/14622200110050510
  • [19] Relationship between systemic markers of inflammation and serum β-carotene levels
    Erlinger, TP
    Guallar, E
    Miller, ER
    Stolzenberg-Solomon, R
    Appel, LJ
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (15) : 1903 - 1908
  • [20] Serum carotenoid concentrations in US children and adolescents
    Ford, ES
    Gillespie, C
    Ballew, C
    Sowell, A
    Mannino, DM
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 76 (04) : 818 - 827